Heptane

Heptane

SCHEMBL7200232

CC#N.CC(C)O.CCCCCCC.O=CO

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.42
ADH1B P00325 2/20 0.39
ADH1C P00326 2/20 0.39
ADH1A P07327 2/20 0.39
ADH4 P08319 2/20 0.39
ADH7 P40394 2/20 0.39
TSHR P16473 2/20 0.39
TRPA1 O75762 1/20 0.38
DDAH1 O94760 1/20 0.38
GAPDH P04406 1/20 0.38
MAPT P10636 1/20 0.38
GPR84 Q9NQS5 3/20 0.38
FFAR1 O14842 1/20 0.38
EPHX1 P07099 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Heptane SCHEMBL2836497 0.89 SPHK1 (0.50) SPHK1TSHRMAPTGPR84FFAR1
Heptane SCHEMBL5203374 0.89 TSHR (0.48) SPHK1ADH1BADH1CADH1AADH4
Hexane SCHEMBL28528904 0.86 TSHR (0.40) ADH1BADH1CADH1AADH4ADH7
Hexane SCHEMBL1889283 0.86 TSHR (0.48) SPHK1TSHRMAPTGPR84FFAR1
Hexane SCHEMBL720450 0.86 TRPA1 (0.46) SPHK1ADH1BADH1CADH1AADH4
Isopropyl Alcohol SCHEMBL1280109 0.83 ALDH1A1 (0.38) TSHR
Isopropyl Alcohol SCHEMBL28456192 0.83 ALDH1A1 (0.38) TSHR
Hexane SCHEMBL15911551 0.82 TSHR (0.37) ADH1BADH1CADH1AADH4ADH7
Isopropyl Alcohol SCHEMBL29165312 0.81 ALDH1A1 (0.35) TSHR
Isopropyl Alcohol SCHEMBL28882754 0.81 ALDH1A1 (0.35) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6599894-B1 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants AstŕaZeneca AB (SE) 2003-07-29 US disclosed